论文部分内容阅读
我们于1981年2～5月,用四川抗菌素工业研究所等试制的丁胺卡那霉素,治疗急性化脓性感染22例,报告如下。病例与方法病例选择随机选择急性化脓性感染住院病人22例(男14例,女8例,年龄7～62岁)。其中革兰氏阴性杆菌感染12例(化脓性全腹膜炎6例,脓性胆管炎3例,脓性心包炎、乳腺脓肿及后尿道断裂伤感染各1例),金色葡萄球菌感染10例(脓毒血症5例,败血症2例,急性骨髓炎、腹壁脓肿及腰骶部脓肿各1例)。22例中,经细菌学证实者20例(革兰氏阴性杆菌者11例,金色葡萄球菌者9
We in 1981 from 2 to 5 months, with the Sichuan Institute of antibiotics and other trial production of amikacin, acute suppurative infection in 22 cases, the report is as follows. Cases and Methods A total of 22 patients (14 males and 8 females, aged 7-62 years) with acute suppurative infection were randomly selected. Gram-negative bacilli in which infection in 12 cases (purulent peritonitis in 6 cases, purulent cholangitis in 3 cases, purulent pericarditis, breast abscess and urethral injury in 1 case), Staphylococcus aureus infection in 10 cases (pus 5 cases of sepsis, 2 cases of sepsis, acute osteomyelitis, abdominal abscess and lumbosacral abscess in 1 case). In 22 cases, 20 cases were confirmed by bacteriology (Gram-negative bacilli in 11 cases, Staphylococcus aureus 9